Publikationen der ALS-Forschungsgruppe an der Charité
Provision of assistive technology devices among people with ALS in Germany: a platform-case management approach
Funke A, Spittel S, Grehl T, Grosskreutz J, Kettemann D, Petri S,
Clinical characteristics and course of dying in patients with amyotrophic lateral sclerosis withdrawing from long-term ventilation
Kettemann D, Funke A, Maier A, Rosseau S, Meyer R, Spittel S,
Interleukin-1 Antagonist Anakinra in Amyotriphic Lateral Sclerosis – A Pilot Study
Maier A, Deigendesch N, Müller K, Weishaupt JH, Krannich A, Röhle R,
Provision of assistive devices in amyotrophic lateral sclerosis. Analysis of 3 years case management in an internet-based supply network
Funke A, Grehl T, Großkreutz J, Münch C, Walter B, Kettemann D,
Severe loss of appetite in amyotrophic lateral sclerosis patients: online self-assessment study
Holm T, Maier A, Wicks P, Lang D, Linke P, Münch C,
Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?
Borisow N, Meyer T, Paul F. Concomitant amyotrophic lateral sclerosis and paraclinical
Publikationen mit Beteiligung der ALS-Forschungsgruppe an der Charité
A mapping review of international guidance on the management and care of amyotrophic lateral sclerosis (ALS)
Janssens AI, Ruytings M, Al-Chalabi A,
Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis
Vercruysse P, Sinniger J, El Oussini
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
Freischmidt A, Wieland T, Richter B,
Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study
Dorst J, Dupuis L, Petri S,
A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity
Joyce PI, Mcgoldrick P, Saccon RA,
Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression
Küffner R, Zach N, Norel R,
Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study
van Doormaal PT, Ticozzi N, Gellera
A phase II-III trial of olesoxime in subjects with amyotrophic lateral sclerosis
Lenglet T, Lacomblez L, Abitbol JL,
Live and let die: existential decision processes in a fatal disease
Lulé D, Nonnenmacher S, Sorg S,
In vivo waveguide elastography: effects of neurodegeneration in patients with amyotrophic lateral sclerosis
Romano A, Guo J, Prokscha T, Meyer
